Effect of carbenoxolone upon immunoreactive secretin in patients with rheumatoid arthritis.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000906:Antibodies; D000941:Antigens; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D002245:Carbon Dioxide / Q000097:blood; D002712:Chlorides / Q000097:blood; D005260:Female; D005755:Gastrins / Q000097:blood; D006035:Glycyrrhiza; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy; D010946:Plants, Medicinal; D011188:Potassium / Q000097:blood; D011863:Radioimmunoassay; D012633:Secretin / Q000097:blood*; D012964:Sodium / Q000097:blood; D013386:Succinates / Q000008:administration & dosage / Q000627:therapeutic use; D014315:Triterpenes / Q000008:administration & dosage / Q000627:therapeutic use*
D000906:Antibodies; D000941:Antigens; D002712:Chlorides; D005755:Gastrins; D013386:Succinates; D014315:Triterpenes; D012633:Secretin; D002245:Carbon Dioxide; D012964:Sodium; D011188:Potassium